Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (191-200 of 528) with videos related to

Pageof 53
Sort By:
Translational Lung Cancer Research|July 10, 2023
Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patientsJu-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, et al.
British Journal of Cancer|January 25, 2007
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levelsK S M Smalley, R Contractor, N K Haass, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2024
Multi-ethnic heterozygote frequencies of cancer susceptibility genes to inform counseling of reproductive riskJacquelyn Powers, Heather Wachtel, Erica Trujillo, et al.
Molecular Carcinogenesis|June 7, 2018
Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestryShengfeng Wang, Dezheng Huo, Temidayo O Ogundiran, et al.
Breast Cancer Research and Treatment|November 4, 2009
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2S M Domchek, M M Gaudet, J E Stopfer, et al.
Journal of Medical Genetics|August 8, 2025
Exploration of possible association of <i>BRIP1</i> pathogenic variants with central nervous system cancers in an institutional cohortJacqueline Cappadocia, Kara N Maxwell, Katherine L Nathanson, et al.
American Journal of Human Genetics|September 14, 2000
Association of HPC2/ELAC2 genotypes and prostate cancerT R Rebbeck, A H Walker, C Zeigler-Johnson, et al.
Carcinogenesis|June 6, 2017
Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' ConsortiumShengfeng Wang, Dezheng Huo, Temidayo O Ogundiran, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 24, 2020
Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)Marilyn M Li, Elizabeth Chao, Edward D Esplin, et al.
Familial Cancer|September 8, 2011
Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomyJ V Cohen, L Chiel, L Boghossian, et al.
Pageof 53

Showing results (191-200 of 528) with videos related to

Sort By:
Pageof 53
Translational Lung Cancer Research|July 10, 2023
Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patientsJu-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, et al.
British Journal of Cancer|January 25, 2007
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levelsK S M Smalley, R Contractor, N K Haass, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2024
Multi-ethnic heterozygote frequencies of cancer susceptibility genes to inform counseling of reproductive riskJacquelyn Powers, Heather Wachtel, Erica Trujillo, et al.
Molecular Carcinogenesis|June 7, 2018
Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestryShengfeng Wang, Dezheng Huo, Temidayo O Ogundiran, et al.
Breast Cancer Research and Treatment|November 4, 2009
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2S M Domchek, M M Gaudet, J E Stopfer, et al.
Journal of Medical Genetics|August 8, 2025
Exploration of possible association of <i>BRIP1</i> pathogenic variants with central nervous system cancers in an institutional cohortJacqueline Cappadocia, Kara N Maxwell, Katherine L Nathanson, et al.
American Journal of Human Genetics|September 14, 2000
Association of HPC2/ELAC2 genotypes and prostate cancerT R Rebbeck, A H Walker, C Zeigler-Johnson, et al.
Carcinogenesis|June 6, 2017
Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' ConsortiumShengfeng Wang, Dezheng Huo, Temidayo O Ogundiran, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 24, 2020
Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)Marilyn M Li, Elizabeth Chao, Edward D Esplin, et al.
Familial Cancer|September 8, 2011
Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomyJ V Cohen, L Chiel, L Boghossian, et al.
Pageof 53